Meticulous Research® Forecasts Global In Vitro Diagnostics (IVD) Market to Reach $116.28 Billion by 2031

Meticulous Research®, a globally recognized leader in market intelligence, has unveiled its latest report titled "In Vitro Diagnostics (IVD) Market Size, Share, Forecast, & Trends Analysis by Offering (Kits), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS], Rapid Test), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2031." This comprehensive report projects that the global in vitro diagnostics market will experience a compound annual growth rate (CAGR) of 5.3%, reaching a market size of $116.28 billion by 2031.

Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=4858

Meticulous Research®, a globally recognized leader in market intelligence, has unveiled its latest report titled "In Vitro Diagnostics (IVD) Market Size, Share, Forecast, & Trends Analysis by Offering (Kits), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS], Rapid Test), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2031." This comprehensive report projects that the global in vitro diagnostics market will experience a compound annual growth rate (CAGR) of 5.3%, reaching a market size of $116.28 billion by 2031.

Market Growth Drivers and Opportunities

The expansion of the global in vitro diagnostics market is driven by several key factors, including the escalating prevalence of chronic and infectious diseases, an aging global population, and a heightened demand for early and accurate disease diagnosis. Additional factors such as increasing investments in healthcare research, growing awareness of point-of-care (POC) diagnostics, and rising healthcare expenditures are also contributing to this upward trajectory.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/pressrelease/198/ivd-market-2031

Emerging economies and advancements in personalized medicine, genomics, and proteomics present substantial opportunities for market participants. However, challenges such as stringent regulatory requirements and variability in test results, particularly in rapid IVD tests, may impede market growth. The evolving regulatory landscape also poses significant challenges for companies operating within this sector.

Competitive Landscape

The report identifies key players shaping the future of the in vitro diagnostics market, including:

Abbott Laboratories (U.S.)
Becton, Dickinson and Company (U.S.)
bioMérieux SA (France)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Illumina, Inc. (U.S.)
QIAGEN N.V. (Netherlands)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Siemens Healthineers AG (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Wama Diagnostica (Brazil)
Wiener Laboratorios SAIC (Argentina)
QuidelOrtho Corporation (U.S.)
Agilent Technologies Inc. (U.S.)
DiaSorin S.p.A. (Italy)

These industry leaders are continuously innovating and forming strategic alliances to enhance their market positions. For instance, in May 2022, QIAGEN N.V. introduced the therascreen EGFR RGQ PCR Kit, a cutting-edge diagnostic tool designed for sensitive EGFR mutation analysis.

Segment Analysis and Regional Insights

The report provides an in-depth analysis of the IVD market segmented by offering, technology, application, diagnostic approach, end-user, and geography.

Quick Buy - https://www.meticulousresearch.com/Checkout/87380450

Offering: The reagents and kits segment is projected to dominate the market with an 81.1% share in 2024, driven by the consistent demand for diagnostic assays and kits.
Technology: Molecular diagnostics, accounting for 23.1% of the market in 2024, is expected to lead due to the rising prevalence of infectious diseases and the adoption of advanced molecular techniques.

Application: The infectious diseases segment is anticipated to hold a 37.8% market share, fueled by ongoing global health challenges and governmental initiatives.

Diagnostic Approach: Lab testing is set to remain the preferred diagnostic method, attributed to its comprehensive capabilities and skilled workforce.

End-User: Diagnostic laboratories are expected to account for the largest market share, supported by technological advancements and increased automation.
Geographical Outlook

North America is predicted to maintain its market leadership, representing 37.5% of the global in vitro diagnostics market in 2024. The region's dominance is underpinned by the high prevalence of chronic and infectious diseases, robust healthcare infrastructure, and significant investments in diagnostic technology advancements.

Request Free Sample PDF Copy Here: https://www.meticulousresearch.com/request-sample-report/cp_id=4858

To explore the detailed insights and forecasts presented in this report, download a sample here: Download Sample Report.

Key Questions Addressed in the Report

Which market segments will exhibit the highest growth?
What were the historical trends in the global IVD market?
What are the projected market forecasts from 2024 to 2031?
What are the main challenges and opportunities in the IVD sector?
Who are the leading players, and what are their market strategies?

Mr. Khushal Bombe
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.